-
31-03-2021, 10:07 AM
#19071
Member
Originally Posted by artemis
The company says not huge, but more important is that it was the urologists that asked for it. And that others in the group will now be more likely to join up as well. Potential snowball effect.
Yeah very good indication they are gaining good traction in the US. Very good news IMHO.
-
31-03-2021, 10:34 AM
#19072
Announcement made just in time to stop the SP dropping below the 100 day MA
-
31-03-2021, 10:51 AM
#19073
Member
Facey website lists 4 urologists on staff.
If we make a few assumptions, we can get an extremely rough ballpark figure.
1) Assume all four include cxbladder in their processes.
2) Assume each urologist refers a single patient for one of the cxbladder tests once per day. (Biggest assumption, I have no basis for this one, someone with knowledge please chip in..)
3) Assume Facey are paying the same CMS-agreed rate of US$760 per test.
4) Assume 48 clinic weeks a year, gotta let them rest sometime.
4 Urologists x 5 tests a week x 48 weeks x $760 = $729,600 USD potential contribution to revenue.
As above.. all assumptions. Final figure could be a 10% of this number, could be double, or something else entirely. Would dearly love to hear from someone experienced who could zero in on how many patients a Urologist may have cause to refer for testing in any given week.
Overall, I feel this is more a potential foot in the door to another large payer, and consider it an extremely good sign that they sought out PEB themselves after using the tests and finding them beneficial.
-
31-03-2021, 11:14 AM
#19074
Originally Posted by artemis
The company says not huge, but more important is that it was the urologists that asked for it. And that others in the group will now be more likely to join up as well. Potential snowball effect.
You hit the nail on the head!
-
31-03-2021, 11:51 AM
#19075
This is important but seems to be missed:
Facey Medical Group is a multi-specialty medical group with over 180 physicians providing care to more than 170,000 patients in the North & East regions of Los Angeles & Ventura Counties in California. This makes it similar in size to the Mid-Central District Health Board in New Zealand. Facey Medical Group is also one of six California physician groups affiliated with, or owned by Providence Health & Services, one of the largest health systems in the Western United States.
Also it is not just about urologists as some physicians will be involved as well. So a bit hard to put any kind of figure on it.
Last edited by Minerbarejet; 31-03-2021 at 03:35 PM.
-
31-03-2021, 01:01 PM
#19076
I’m heavily invested in both PEB and IKE and great to see them both making steady progress in USA. Both featuring on the leaderboard today. Onwards and upwards.
-
31-03-2021, 02:43 PM
#19077
Originally Posted by Left field
I’m heavily invested in both PEB and IKE and great to see them both making steady progress in USA. Both featuring on the leaderboard today. Onwards and upwards.
Very positive news. We have family members who are doctors/ urologists US based and apparently CX is starting to be heard of and abuzz. Integration is likely to follow more mainstream public health sectors as positive reviews flow. This is a good stepping stone, and the recognition here is wonderful for PEB. Great news. We will secure some more shares while the SP is still low at 1.02. This will seem like a bargain price within a short period of time. Looks like the analysts targets of 1.4 within the year is well on the cards
-
31-03-2021, 03:04 PM
#19078
probably seen this before as it's from early Feb https://www.urologytimes.com/view/bladder-cancer-biomarker-test-accurately-adjudicates-atypical-cytology
Some good, positive publicity for CXBladder's effectiveness.
-
01-04-2021, 11:01 AM
#19079
Member
Originally Posted by Maxtrade
Very positive news. We have family members who are doctors/ urologists US based and apparently CX is starting to be heard of and abuzz. Integration is likely to follow more mainstream public health sectors as positive reviews flow. This is a good stepping stone, and the recognition here is wonderful for PEB. Great news. We will secure some more shares while the SP is still low at 1.02. This will seem like a bargain price within a short period of time. Looks like the analysts targets of 1.4 within the year is well on the cards
I recently spoke with a young NZ Urologist who’s opinion was that PEB was a definite “hold”. I was prompted to make another modest accumulation. When do we expect the March announcement?
-
01-04-2021, 11:06 AM
#19080
Full Year result 28th May. As for Investor Update - any day..
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks